Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05363280 |
| Title | AL8326 in SCLC Treatment |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Advenchen Pharmaceuticals, LLC. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | United States | Details | |
| Northwestern University | Chicago | Illinois | 60611 | United States | Details | |
| Siteman Cancer Center, Washington University | St Louis | Missouri | 63130 | United States | Details | |
| Cleveland Clinic | Cleveland | Ohio | 44195 | United States | Details | |
| Hospital Universitari Vall d'Hebron | Barcelona | Spain | Details | |||
| Hospital Universitario Ramón Y Cajal | Madrid | Spain | Details |